US 11,904,162 B2
Biostimulator having resilient scaffold
Thomas B. Eby, Mountain View, CA (US); Alex C. Soriano, Ventura, CA (US); and Mark Carlson, Calabasas, CA (US)
Assigned to PACESETTER, INC., Sylmar, CA (US)
Filed by Pacesetter, Inc., Sylmar, CA (US)
Filed on Aug. 10, 2022, as Appl. No. 17/885,528.
Application 17/885,528 is a continuation of application No. 16/791,785, filed on Feb. 14, 2020, granted, now 11,413,453.
Claims priority of provisional application 62/807,189, filed on Feb. 18, 2019.
Prior Publication US 2022/0379110 A1, Dec. 1, 2022
Int. Cl. A61N 1/05 (2006.01); A61N 1/375 (2006.01); A61N 1/378 (2006.01)
CPC A61N 1/0573 (2013.01) [A61N 1/3756 (2013.01); A61N 1/3787 (2013.01); A61N 1/37512 (2017.08); A61N 2001/058 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A biostimulator, comprising:
a housing having a longitudinal axis and an electronics compartment containing a processor configured to stimulate a target tissue;
a helical fixation element coupled to the housing and having a piercing tip;
an elongated member extending distally from the housing to a tissue contact region; and
an electrode mounted on the elongated member at the tissue contact region, wherein, when the biostimulator is in an undeployed state with the helical fixation element unattached to the target tissue, the electrode is longitudinally distal to the piercing tip, and wherein, when the biostimulator is in a deployed state with the helical fixation element attached to the target tissue, the electrode is longitudinally proximal to the piercing tip.